Page:United States Statutes at Large Volume 107 Part 1.djvu/232

 107 STAT. 206 PUBLIC LAW 103-43—JUNE 10, 1993 (A) the Coimties of Nassau and Suffolk, in the State of New York; and (B) the 2 counties in the northeastern United States that, as identified in the report specified in paragraph (2), had the highest age-adjusted mortality rate of such cancer that reflected not less than 30 deaths during the 5-year period for which findings are made in the report. (2) RELEVANT REPORT. —The report referred to in paragraph (1)(B) is the report of the findings made in the study entitled " Survival, Epidemiology, and End Results", relating to cases of cancer during the years 1983 through 1987. (b) CERTAIN ELEMENTS OF STUDY. —Activities of the Director in carrying out the study under subsection (a) shall include the use of a geographic system to evaluate the current and past exposure of individuals, including direct monitoring and cumulative estimates of exposure, to— (1) contaminated drinking water; (2) sources of indoor and ambient air pollution, including emissions from aircraft; (3) electromagnetic fields; (4) pesticides and other toxic chemicals; (5) hazardous and mtinicipal waste; and (6) such other factors as the Director determines to be appropriate. (c) REPORT.— Not later than 30 months after the date of the enactment of this Act, the Director shall complete the study required in subsection (a) and submit to the Committee on Energy and Commerce of the House of Representatives, and to the Committee on Labor and Human Resources of the Senate, a report describing the findings made as a result of the study. (d) FUNDING.—O f the amounts appropriated for fiscal years 1994 and 1995 for the National Institute of Environmental Health Sciences and the National Cancer Institute, the Director of the National Institutes of Health shall make available amounts for carrying out the study required in subsection (a). 42 USC 282 note. SEC. 1912. SUPPORT FOR BIOENGINEERING RESEARCH. (a) STUDY. —The Secretary of Health and Human Services, acting through the Director of the National Institutes of Health, shall conduct a study for the purpose of— (1) determining the sources and amoiuits of public and private funding devoted to basic research in bioengineering, including biomaterials sciences, cellular bioprocessing, tissue and rehabilitation engineering; (2) evaluating whether that commitment is sufificient to maintain the innovative edge that the United States has in these technologies; (3) evaluating the role of the National Institutes of Health or any other Federal agency to achieve a greater commitment to innovation in bioengineering; and (4) evaluating the need for better coordination and collaboration among Federal agencies and between the public and private sectors. In conducting such study, the Director shall work in conjunction with appropriate organizations and representatives including academics, industry leaders, bioengineering societies, and public agencies.

�